Haemophilus influenzae type b conjugate vaccines

Immunology
Dominic F KellyAndrew J Pollard

Abstract

Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial infection in young children worldwide. During childhood, acquisition of antibody directed against the polysaccharide capsule of the organism, presumably as a result of asymptomatic carriage, confers protection and disease is much less common after the age of 4 years. Like other polysaccharides, the polyribosyl ribitol phosphate (PRP) of the Hib capsule is a T-independent antigen and not immunogenic when administered as a vaccine in infancy. Because the highest rates of disease occur in the first 2 years of life, efficacious Hib vaccines have been designed by covalently linking the PRP capsule to a carrier protein that recruits T-cell help for the polysaccharide immune response and induces anti-PRP antibody production even in the first 6 months of life. Introduction of Hib protein-polysaccharide conjugate vaccines into many industrialized countries over the past 15 years has resulted in the virtual elimination of invasive Hib disease. However, despite the success of the vaccine programme several factors may interfere with the effectiveness of the vaccine in the routine programme, as observed in the UK recently. Such factors may include interfe...Continue Reading

References

Oct 1, 1978·The Journal of Infectious Diseases·P F WellerP Anderson
Mar 18, 1992·JAMA : the Journal of the American Medical Association·Y Schlesinger, D M Granoff
Jun 1, 1992·The Journal of Infectious Diseases·S J Holmes, D M Granoff
Jun 1, 1992·The Journal of Infectious Diseases·J A Winkelstein, E R Moxon
Feb 1, 1992·The Journal of Pediatrics·M D DeckerP Palmer
Feb 1, 1991·American Journal of Diseases of Children·H KäyhtyL Saarinen
Jan 1, 1990·Current Topics in Microbiology and Immunology·E R Moxon, J S Kroll
Sep 17, 1987·The New England Journal of Medicine·J EskolaJ S Samuelson
Jan 1, 1987·Drugs·J SymondsA Javaid
Jan 1, 1972·The Journal of Clinical Investigation·P AndersonD H Smith
Jan 1, 1972·CRC Critical Reviews in Clinical Laboratory Sciences·R B Newman
Jun 1, 1983·The Journal of Infectious Diseases·H KäyhtyP H Mäkelä
Nov 1, 1983·The Journal of Allergy and Clinical Immunology·M E Pichichero, R A Insel
May 5, 1995·Science·C ArpinY J Liu
Dec 1, 1994·Biologicals : Journal of the International Association of Biological Standardization·H Käyhty
Jan 1, 1995·The Journal of Infectious Diseases·M L BarbourE R Moxon
Aug 1, 1993·Archives of Disease in Childhood·R BooyE R Moxon
Sep 1, 1993·The Journal of Infectious Diseases·D M GranoffT V Murphy
Jan 13, 1993·JAMA : the Journal of the American Medical Association·T V MurphyM T Osterholm

❮ Previous
Next ❯

Citations

Nov 26, 2013·The Lancet Infectious Diseases·Marina Ulanova, Raymond S W Tsang
Apr 7, 2005·Nature Medicine·Paul-Henri LambertClaire-Anne Siegrist
Oct 7, 2006·Nature Reviews. Immunology·Sarkis K Mazmanian, Dennis L Kasper
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yeh Chen LeeAndrew J Pollard
Feb 15, 2008·The Journal of Infectious Diseases·Martin C J MaidenJames M Stuart
Mar 16, 2012·The Pediatric Infectious Disease Journal·Jane Astrid MetzAndrew John Pollard
Oct 3, 2009·Current Opinion in Infectious Diseases·Andrew C SteerJonathan R Carapetis
Aug 11, 2007·Journal of Paediatrics and Child Health·Joanna S HawkesRobert A Gibson
Jan 13, 2010·Clinical Microbiology Reviews·John S Tregoning, Jürgen Schwarze
Nov 5, 2010·Clinical and Vaccine Immunology : CVI·Luigi BuonaguroFranco M Buonaguro
Aug 23, 2005·Infection and Immunity·Karin BaraldoGiuseppe Del Giudice
Apr 25, 2008·PLoS Medicine·M Carolina Danovaro-HollidayJon K Andrus
Apr 24, 2007·CNS Drugs·Nick Makwana, F Andrew I Riordan
Oct 1, 2008·Clinical & Developmental Immunology·Peter Klein Klouwenberg, Louis Bont
Jan 10, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K P PerrettA J Pollard
Jun 3, 2009·Expert Review of Vaccines·Stephen I Pelton, Gregory P Gilmet
Jun 12, 2013·Expert Review of Vaccines·Kerstin WennholdMichael von Bergwelt-Baildon
Jul 14, 2011·Expert Review of Vaccines·Stanley A PlotkinEsteban Ortiz
Aug 13, 2009·Expert Review of Pharmacoeconomics & Outcomes Research·Ulla K Griffiths, Alec Miners
Dec 24, 2005·Expert Review of Vaccines·Aruna ChandranMathuram Santosham
Jul 26, 2012·Expert Review of Vaccines·Vassiliki Papaevangelou, Nikos Spyridis
Nov 13, 2013·Journal of Infection and Public Health·Prashant PurohitNehad Gamal Al-Deen Omar
Oct 16, 2015·Vaccine·Yimin WuAnjali Yadava
Jul 20, 2010·Archives of Medical Research·Patricia Gómez de León CrucesJose Ignacio Santos
Dec 17, 2009·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hiroshi SakataKeisuke Sunakawa
Sep 9, 2008·Trends in Microbiology·Gunilla KälleniusStefan B Svenson
Feb 1, 2005·European Journal of Immunology·Brian A Cobb, Dennis L Kasper
Jan 1, 2007·Influenza and Other Respiratory Viruses·Konstantin MusiychukVidadi Yusibov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.